NeuRA Libraries
- 
					
Bipolar Disorders Library
- Diagnosis and assessment
 - 
				
					
					Signs and symptoms
				
					
- General signs and symptoms
 - 
				
					
					Cognition
				
					
- Attention
 - Cognition and bipolar disorder symptoms
 - Cognition and bipolar disorder type
 - Cognition and functioning
 - Cognition in bipolar disorder and major depression
 - Cognition in bipolar disorder and schizophrenia
 - Cognition in children with bipolar disorder
 - Cognition in first-episode bipolar disorder
 - Cognition in late-life bipolar disorder
 - Cognition in relatives
 - Decision making
 - Episodic future thinking
 - Executive functioning
 - Insight
 - IQ and global cognition
 - Language
 - Learning
 - Memory
 - Metacognition
 - Processing speed
 - Reasoning and problem solving
 - Social cognition
 - Visuospatial ability
 
 
 - 
				
					
					Treatments
				
					
- 
				
					
					Physical
				
					
- Non-pharmaceutical
 - 
				
					
					Pharmaceutical
				
					
- Mood stabilisers
 - Antidepressants
 - Antipsychotics
 - Adjunctive and alternative treatments
 - 
				
					
					Medications for specific symptoms and populations
				
					
- Medication during pregnancy and breastfeeding
 - Medication for aggression and agitation
 - Medication for bipolar II disorder
 - Medication for bipolar versus unipolar depression
 - Medication for children
 - Medication for cognitive symptoms
 - Medication for dual diagnosis
 - Medication for elderly people
 - Medication for first-episode bipolar disorder
 - Medication for high-risk groups
 - Medication for mixed states
 - Medication for rapid cycling
 - Medication for relapse prevention
 - Medication for suicide and self-harm prevention
 - Medication for treatment resistance
 
 - Other pharmaceutical topics
 
 
 - 
				
					
					Psychotherapy
				
					
- Therapies
 - 
				
					
					Therapies for specific symptoms and populations
				
					
- Therapies for children
 - Therapies for cognition
 - Therapies for dual diagnosis
 - Therapies for first-episode bipolar disorder
 - Therapies for high-risk groups
 - Therapies for internalised stigma
 - Therapies for parents with bipolar disorder
 - Therapies for trauma-related symptoms
 - Therapies for treatment non-adherence
 - Therapies for weight gain
 
 
 
 - 
				
					
					Physical
				
					
 - 
				
					
					Risk factors and antecedents
				
					
- Antecedents
 - 
				
					
					Environmental risk factors
				
					
- Adult life events
 - Childbirth
 - Childhood adversity
 - Environmental toxins
 - Ethnicity
 - Familial factors
 - Infectious agents
 - Maternal diet during pregnancy
 - Maternal illness during pregnancy
 - Migration
 - Obstetric complications
 - Parental age at birth
 - Parental education
 - Parental psychological factors
 - Rheumatoid arthritis
 - Sibship
 - Socioeconomic status
 - Substance use
 - Traumatic brain injury
 - Urbanicity
 - Winter birth
 
 
 - 
				
					
					Illness course and outcomes
				
					
- Absconding
 - Age at onset
 - Attitudes to medication
 - Creativity
 - Criminal offending, aggression and violence
 - Criminal victimisation
 - Cultural differences
 - Dietary intake
 - Drug and alcohol use
 - Employment
 - First-episode bipolar disorder
 - Functional outcomes
 - Homelessness
 - Hope
 - Menopause
 - Mortality
 - Parenthood
 - Pathways to care
 - Pediatric bipolar disorder
 - Physical activity
 - Physical health monitoring
 - Quality of care
 - Quality of life
 - Recovery
 - Relapse
 - Relationships
 - Religiosity
 - Smoking
 - Stigma
 - Suicide and self-harm
 - Treatment non-adherence
 - Treatment resistance
 
 - Insights for families
 - 
				
					
					Physical features
				
					
- 
				
					
					Functional changes
				
					
- Body functioning
 - 
				
					
					Biochemical changes
				
					
- Brain pH and lactate
 - Calcium
 - Complex I and IV
 - Dopamine
 - GABA
 - Gut microbiota
 - Homocysteine
 - Hypothalamic-pituitary-adrenal axis
 - Infectious agents
 - Inflammation and immune system dysfunction
 - Insulin-like growth factor
 - Lipids
 - Neurometabolites
 - Neuropeptides
 - Neurotrophins
 - NMDA receptor function
 - Oxidative stress
 - S100 proteins
 - Serotonin
 - Vitamin B
 
 - Cerebral blood flow and metabolism
 - Electrophysiology
 
 - Structural changes
 
 - 
				
					
					Functional changes
				
					
 - 
				
					
					Co-occurring conditions
				
					
- Mental disorders
 - 
				
					
					Physical disorders
				
					
- Asthma
 - Autoimmune disease
 - Blood disorders
 - Cancer
 - Cerebrovascular disease
 - Dementia
 - Diabetes
 - Digestive disorders
 - Epilepsy
 - Fibromyalgia
 - Heart disease
 - Infectious diseases
 - Metabolic syndrome
 - Musculoskeletal and connective tissues
 - Obesity
 - Optical alterations
 - Osteoporosis
 - Pain and migraine
 - Parkinson’s disease
 - Peripheral vascular disease
 - Premenstrual syndrome
 - Respiratory disease
 - Skin disorders
 - Sleep apnea
 - Thyroid disorders
 - Venous thromboembolism
 - Visual impairment
 - Wilson’s disease
 
 - Substance use
 
 - 
				
					
					Incidence and prevalence
				
					
- General
 - Incidence
 - 
				
					
					Prevalence
				
					
- Prevalence in children
 - Prevalence in elderly people
 - Prevalence in forensic settings
 - Prevalence in homeless populations
 - Prevalence in indigenous populations
 - Prevalence in males vs. females
 - Prevalence in migrants
 - Prevalence in primary care settings
 - Prevalence in problem gamblers
 - Prevalence in veterans
 - Spatial variation in prevalence
 - Worldwide prevalence
 
 
 - General information
 
 - 
					
Post-Traumatic Stress Disorder Library
- Diagnosis and assessment
 - Signs and symptoms
 - 
				
					
					Treatments
				
					
- Physical
 - 
				
					
					Psychotherapy
				
					
- 
				
					
					Therapies
				
					
- Acceptance and commitment therapy
 - All psychological therapies for PTSD
 - Animal-assisted psychotherapy
 - Brief eclectic psychotherapy
 - Cognitive behavioural therapy
 - Cognitive therapies
 - Creative arts therapy
 - Emotion-focussed therapies
 - Emotional freedom techniques
 - Exposure therapies
 - Expressive writing
 - Eye movement desensitization and reprocessing
 - Family therapies
 - Group therapies
 - Hypnotherapy
 - ICU diaries
 - Imagery rehearsal therapy
 - Interpersonal psychotherapy
 - Memory specificity training
 - Metacognitive therapy
 - Mindfulness and meditation
 - Narrative exposure therapy
 - Present-centred therapy
 - Psychoeducation
 - Self-help treatment
 - Stress inoculation training
 - Stress management
 - Structured approach therapy
 - Supportive counselling
 - Telemental health
 - Trauma affect regulation
 
 - 
				
					
					Therapies for specific symptoms and populations
				
					
- Therapies for adults with a history of childhood abuse
 - Therapies for children and adolescents
 - Therapies for complex PTSD
 - Therapies for dual diagnosis
 - Therapies for people living in low- and middle-income countries
 - Therapies for prevention of PTSD
 - Therapies for refugees and asylum seekers
 - Therapies for soldiers and veterans
 
 
 - 
				
					
					Therapies
				
					
 
 - 
				
					
					Risk factors
				
					
- Personal characteristics
 - 
				
					
					Trauma characteristics
				
					
- Abuse and violence
 - Bereavement
 - Direct vs. indirect exposure
 - Disasters
 - Epidemics and pandemics
 - Imprisonment
 - Intentional vs. unintentional traumas
 - Interpersonal vs. non-interpersonal traumas
 - Migration and displacement
 - Moral injury
 - Physical injury and illness
 - Pregnancy and childbirth
 - Road traffic accidents
 - Time post-trauma
 - Trauma severity
 - War and terrorism
 
 
 - Illness course and outcomes
 - Insights for families
 - Physical features
 - Co-occurring conditions
 - 
				
					
					Incidence and prevalence
				
					
- 
				
					
					Incidence
				
					
- Incidence in abuse and violence survivors
 - Incidence in bereaved people
 - Incidence in caregivers
 - Incidence in children and adolescents
 - Incidence in criminal offenders
 - Incidence in disaster survivors
 - Incidence in elderly people
 - Incidence in epidemic and pandemic survivors
 - Incidence in firefighters
 - Incidence in healthcare workers
 - Incidence in homeless populations
 - Incidence in humanitarians
 - Incidence in indigenous people
 - Incidence in journalists
 - Incidence in jurors
 - Incidence in males vs. females
 - Incidence in medical patients
 - Incidence in police officers
 - Incidence in problem gamblers
 - Incidence in psychiatric inpatients
 - Incidence in public transport drivers
 - Incidence in refugees and asylum seekers
 - Incidence in rescue teams
 - Incidence in road traffic accident survivors
 - Incidence in soldiers and veterans
 - Incidence in war and terrorism survivors
 - Worldwide incidence
 
 - 
				
					
					Prevalence
				
					
- Prevalence in abuse and violence survivors
 - Prevalence in bereaved people
 - Prevalence in caregivers
 - Prevalence in children and adolescents
 - Prevalence in disaster survivors
 - Prevalence in elderly people
 - Prevalence in epidemic and pandemic survivors
 - Prevalence in firefighters
 - Prevalence in forensic settings
 - Prevalence in healthcare workers
 - Prevalence in homeless populations
 - Prevalence in humanitarians
 - Prevalence in indigenous people
 - Prevalence in journalists
 - Prevalence in jurors
 - Prevalence in males vs. females
 - Prevalence in medical patients
 - Prevalence in police officers
 - Prevalence in problem gamblers
 - Prevalence in psychiatric patients
 - Prevalence in refugees
 - Prevalence in rescue teams
 - Prevalence in road traffic accident survivors
 - Prevalence in soldiers and veterans
 - Prevalence in train drivers
 - Prevalence in war and terrorism survivors
 - Spatial variation in prevalence
 - Worldwide prevalence
 
 
 - 
				
					
					Incidence
				
					
 - General information
 
 - 
					
Schizophrenia Library
- Diagnosis and assessment
 - 
				
					
					Signs and symptoms
				
					
- 
				
					
					General signs and symptoms
				
					
- Attachment styles
 - Dermatoglyphics
 - Disorganised symptoms
 - Dissociation
 - Early detection
 - Functional laterality
 - Minor physical anomalies
 - Morphometrics
 - Movement disorders
 - Negative symptoms
 - Neurological soft signs
 - Olfactory functioning
 - Pain sensitivity
 - Personality and temperament
 - Positive symptoms
 - Psychotic relapse
 - Sleep disturbance
 - Temperature regulation
 
 - 
				
					
					Cognition
				
					
- Attention
 - Cognition in high-risk groups
 - Cognition in schizophrenia and bipolar disorder
 - Cognitive functioning related to symptoms
 - Decision making
 - Defeatist performance beliefs
 - Episodic future thinking
 - Executive functioning
 - Information processing
 - Insight
 - IQ and global cognition
 - Language
 - Learning
 - Memory
 - Metacognition
 - Psychomotor ability
 - Reasoning and problem solving
 - Rigidity
 - Social cognition
 - Time perception
 - Tone perception
 - Visuospatial ability
 - Voice patterns
 
 
 - 
				
					
					General signs and symptoms
				
					
 - 
				
					
					Treatments
				
					
- 
				
					
					Physical
				
					
- 
				
					
					Pharmaceutical
				
					
- 
				
					
					First-generation antipsychotics
				
					
- All antipsychotics versus placebo
 - Benperidol
 - Bromperidol
 - Chlorpromazine
 - Droperidol
 - First versus second generation
 - Flupentixol
 - Fluphenazine
 - Fluspirilene
 - Haloperidol
 - Levomepromazine
 - Loxapine
 - Metiapine
 - Molindone
 - Penfluridol
 - Perazine
 - Perphenazine
 - Pimozide
 - Piperacetazine
 - Pipotiazine
 - Sulpiride
 - Thioridazine
 - Trifluoperazine
 - Zuclopenthixol
 
 - 
				
					
					Second-generation antipsychotics
				
					
- All antipsychotics versus placebo
 - Amisulpride
 - Aripiprazole
 - Asenapine
 - Blonanserin
 - Brexpiprazole
 - Cariprazine
 - Carpipramine
 - Clocapramine
 - Clotiapine
 - Clozapine
 - First versus second generation
 - Iloperidone
 - Lurasidone
 - Mosapramine
 - Olanzapine
 - Paliperidone
 - Perospirone
 - Quetiapine
 - Remoxipride
 - Risperidone
 - Second versus second generation
 - Sertindole
 - Ziprasidone
 - Zotepine
 
 - 
				
					
					Adjunctive medications
				
					
- Adenosine modulators
 - Amphetamines
 - Analeptics
 - Anti-inflammatory
 - Anticholinergic
 - Anticonvulsants
 - Anticraving agents
 - Antidepressants
 - Benzodiazepines
 - Beta blockers
 - Calcium channel blockers
 - Catecholamines
 - Cholinergic medications
 - Cholinesterase inhibitors
 - Erythropoietin
 - Essential fatty acids
 - Estrogen
 - GABA agonists
 - GHB
 - Glutamate receptor modulators
 - Herbal medicines
 - Medicinal cannabis
 - Mood stabilisers
 - Oxytocin
 - Promethazine
 - Serotonin modulators
 - Sodium nitroprusside
 - Statins
 - Testosterone
 
 - Alternative medications
 - 
				
					
					Medications for specific symptoms and populations
				
					
- Medications during pregnancy and breastfeeding
 - Medications for aggression and agitation
 - Medications for best adherence
 - Medications for childhood and early-onset schizophrenia
 - Medications for cognitive symptoms
 - Medications for constipation
 - Medications for depressive symptoms
 - Medications for dual diagnosis
 - Medications for elderly people and people with late-onset schizophrenia
 - Medications for first-episode psychosis
 - Medications for hyperprolactinemia
 - Medications for hypersalivation
 - Medications for movement disorders
 - Medications for negative symptoms
 - Medications for relapse prevention
 - Medications for schizoaffective disorder
 - Medications for sexual dysfunction
 - Medications for sleep disturbance
 - Medications for smoking cessation
 - Medications for social functioning
 - Medications for treatment-resistant schizophrenia
 - Medications for weight gain
 - Therapies and medications for high-risk groups
 
 - Other
 - 
				
					
					Side effects
				
					
- Blood disorders
 - Bone density
 - Cancer
 - Cardiometabolic changes and weight gain
 - Constipation
 - Dysphagia
 - Extrapyramidal
 - Hyperprolactinaemia
 - Hypersalivation
 - Hyponatraemia
 - Mortality
 - Neuroleptic malignant syndrome
 - Neutropenia
 - Oculogyric crisis
 - Pancreatitis
 - Polycystic ovarian syndrome
 - Sedation
 - Seizures
 - Sexual dysfunction
 - Thyroid dysfunction
 
 
 - 
				
					
					First-generation antipsychotics
				
					
 - Non-pharmaceutical
 
 - 
				
					
					Pharmaceutical
				
					
 - 
				
					
					Psychotherapy
				
					
- 
				
					
					Therapies
				
					
- Acceptance and commitment therapy
 - Animal-assisted therapy
 - Art and drama therapies
 - Case management
 - Cognitive behavioural therapy
 - Community care
 - Cost
 - Crisis intervention
 - Crisis planning
 - Dance therapy
 - Day centres and day hospitals
 - Dialectical behavioural therapy
 - Distraction techniques
 - Educational therapies
 - Enriched intervention
 - Family intervention
 - Genetics counselling
 - Group therapy
 - Home-based care
 - Hypnosis
 - Inpatient and outpatient care
 - Integrated care
 - Life skills programs
 - Metacognitive training
 - Mindfulness
 - Monetary incentives
 - Morita therapy
 - Music therapy
 - Nidotherapy
 - Open dialogue approach
 - Peer support
 - Physical restraint
 - Prevention programs
 - Problem solving skills training
 - Psychodynamic psychotherapy
 - Shared decision making
 - Strengths-based delivery
 - Supported housing
 - Supportive therapy
 - Telemental health
 - Therapeutic relationship
 - Token economies
 - Trauma-focused therapies
 - User-held records
 - Virtual reality and avatar therapy
 
 - 
				
					
					Therapies for specific symptoms and populations
				
					
- Therapies and medications for high-risk groups
 - Therapies for childhood onset and early onset schizophrenia
 - Therapies for cognition
 - Therapies for dual diagnosis
 - Therapies for fathers with schizophrenia
 - Therapies for first-episode psychosis
 - Therapies for insight
 - Therapies for internalised stigma
 - Therapies for mothers with schizophrenia
 - Therapies for negative symptoms
 - Therapies for positive symptoms
 - Therapies for PTSD symptoms
 - Therapies for quality of life
 - Therapies for schizoaffective disorder
 - Therapies for smoking
 - Therapies for social functioning
 - Therapies for treatment non-adherence
 - Therapies for treatment resistance
 - Therapies for unemployment
 - Therapies for weight gain
 
 
 - 
				
					
					Therapies
				
					
 
 - 
				
					
					Physical
				
					
 - 
				
					
					Risk factors and antecedents
				
					
- 
				
					
					Antecedents
				
					
- Autonomic nervous system anomalies
 - Behavioural disturbances and psychopathology
 - Dermatoglyphic anomalies
 - Eye tracking anomalies
 - Face emotion processing anomalies
 - Height and body mass index
 - IQ and academic performance
 - Minor physical anomalies
 - Motor dysfunction
 - Olfactory identification deficits
 - Sleep disturbance
 - Speech and hearing deficits
 - Stress responsivity anomalies
 
 - 
				
					
					Environmental risk factors
				
					
- Adult life events
 - Childhood adversity
 - Environmental toxins
 - Ethnicity
 - Family relationships
 - Famine
 - Genetic and non-genetic risk
 - Infectious agents
 - Latitude, climate and winter birth
 - Marital status
 - Maternal diet and body mass index
 - Maternal illness during pregnancy
 - Migration
 - Obstetric complications
 - Parental age at birth
 - Parental education
 - Parental psychological factors
 - Sex differences
 - Sibship
 - Social capital
 - Socioeconomic status
 - Substance use
 - Traumatic brain injury
 - Urban environment
 
 - Genetic risk factors
 
 - 
				
					
					Antecedents
				
					
 - 
				
					
					Illness course and outcomes
				
					
- Absconding
 - Age at onset
 - Childhood and early-onset schizophrenia
 - Creativity
 - Criminal offending, aggression and violence
 - Criminal victimisation
 - Cultural differences
 - Diet
 - Drug and alcohol use
 - Duration of untreated psychosis
 - Duration of untreated psychosis and outcomes
 - Electronic device use
 - Employment
 - First-episode psychosis
 - Functional outcomes
 - Homelessness
 - Hope
 - Late-onset schizophrenia
 - Loneliness
 - Mortality
 - Parenthood
 - Pathways to care
 - Physical activity
 - Physical health monitoring
 - Psychotic relapse
 - Quality of care
 - Quality of life
 - Relationships
 - Religiosity
 - Remission and recovery
 - Sex differences
 - Smoking
 - Stigma and attitudes towards mental health
 - Suicide and self-harm
 - Treatment adherence
 - Treatment-resistance
 
 - Insights for families
 - 
				
					
					Physical features
				
					
- 
				
					
					Functional changes
				
					
- Body functioning
 - 
				
					
					Biochemical changes
				
					
- Brain pH and lactate
 - cAMP
 - Cholesterol
 - Dopamine
 - Endocannabinoids
 - GABA
 - Hormonal changes
 - Hypothalamic-pituitary-adrenal axis
 - Infectious agents
 - Inflammation and the immune system
 - Lipids
 - Neurometabolites
 - Neurotrophins
 - Nitric oxide
 - NMDA receptor function
 - Oxidative stress
 - S100 Proteins
 - Serotonin
 - Synaptic proteins
 - Trace elements
 - Vascular endothelial growth factor
 - Vitamin B
 - Vitamin D
 
 - Cerebral blood flow and metabolism
 - Electrophysiology
 
 - Structural changes
 - Brain regions
 
 - 
				
					
					Functional changes
				
					
 - 
				
					
					Co-occurring conditions
				
					
- Mental disorders
 - 
				
					
					Physical disorders
				
					
- Auditory system dysfunction
 - Autoimmune diseases
 - Blood disorders
 - Cancer
 - Cerebrovascular disease
 - Dementia
 - Dental disease
 - Diabetes
 - Digestive disorders
 - Epilepsy
 - Heart disease
 - Infectious diseases
 - Metabolic syndrome
 - Musculoskeletal and connective tissues
 - Obesity
 - Optical alterations
 - Peripheral vascular disease
 - Polycistic ovary syndrome
 - Postoperative complications
 - Reproductive and urological disorders
 - Respiratory system dysfunction
 - Sexual dysfunction
 - Skin disorders
 - Sleep apnea
 - Thyroid disorders
 - Underweight
 - Venous thromboembolism
 
 - Substance use
 
 - 
				
					
					Incidence and prevalence
				
					
- General
 - Incidence
 - 
				
					
					Prevalence
				
					
- Prevalence in children
 - Prevalence in elderly people
 - Prevalence in forensic settings
 - Prevalence in homeless populations
 - Prevalence in indigenous populations
 - Prevalence in inpatients
 - Prevalence in males vs. females
 - Prevalence in migrants
 - Prevalence in refugees
 - Prevalence in veterans and conflict settings
 - Spatial variation in prevalence
 - Worldwide prevalence
 
 
 - General information
 
 - 
					
Podcast Library
 
Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.
		Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.